HEALTH● ELEVATED2h ago · Oct 7, 2026, 9:41 PM
Valneva falls as UK revokes marketing authorization for chikungunya vaccine
Seeking Alpha Tech · western europe
Valneva's stock declined after the UK revoked marketing authorization for its chikungunya vaccine. This regulatory decision impacts the availability of the vaccine and the company's market position.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoMental health experts demand urgent action on Nigeria’s youth crisisVanguard NigeriaHEALTH38m agoRFK Jr. Plans Major Vaccine Injury InitiativeNYT USHEALTH1h agoFlu cases rising faster than any recent season, doctor saysCBS NewsHEALTH1h agoPneumonic plague in Russia: in the town of suspicious death, "nobody seems to care"Clarín